Diabetes News and Research

Latest Diabetes News and Research

VIVUS holds End-of-Review meeting with FDA for QNEXA NDA

VIVUS, Inc. today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity. The meeting occurred on January 19th at the FDA's offices in Maryland and was attended by senior members of the FDA and VIVUS' management and consultants.

21 Jan 2011

What protects certain diabetics from complications?

Much research has been carried out on why diabetics develop complications. Now researchers are asking the question the other way around. They want to know why some diabetic patients do not develop complications. What is it that protects them? The PROLONG study could provide the answer.

21 Jan 2011

Fat linked with DNA chemical changes may help identify risk of cardiovascular disease, diabetes

Fat appears to associate with some distinctive chemical changes in the DNA - a finding that may help explain why obesity can increase the risk for chronic problems such as cardiovascular disease and diabetes, researchers report.

21 Jan 2011

Employees with heart attack, ACS are major source of health costs

Employees with myocardial infarction and other types of acute coronary syndrome are a major source of direct and indirect health costs, reports a study in the January Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

21 Jan 2011

Successful larynx transplant for Californian woman

In a breakthrough, a surgical team in California on Thursday announced that they had successfully replaced the larynx of a 52-year-old woman who hadn’t been able to speak or breathe on her own for more than a decade.

20 Jan 2011

Genetic expression can be modified with natural substances to prevent chronic illness

Research findings demonstrating how genetic expression can be modified with natural substances to prevent chronic illness was the topic of an address by Jeffrey Bland, Ph.D., FACN, FACB, at the 8th Annual Scripps Center for Integrative Medicine 2011 conference in San Diego, California, January 13 - 16.

20 Jan 2011

Novo Nordisk to appeal against ruling in repaglinide combination patent case

Today, Novo Nordisk announced that Judge Avern Cohn of the US District Court for the Eastern District of Michigan issued an adverse ruling in a patent litigation case regarding Novo Nordisk's US Patent No. 6,677,358. The district court ruled that the patent, which covers the combination use of repaglinide and metformin for the treatment of type 2 diabetes, is invalid and unenforceable.

From Novo Nordisk 20 Jan 2011

Takeda Cambridge, Evotec enter collaboration to identify novel modulators against GPCR

Evotec AG today announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule modulators against GPCR and Protease targets involved in various CNS and Metabolic diseases.

20 Jan 2011

Endothelial cells may play a role in controlling cancer behavior: New study

MIT scientists have discovered that cells lining the blood vessels secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.

20 Jan 2011

Prevention launches free content area on diabetes

Today, Prevention—the #1 healthy lifestyle brand in the world—launches Outsmart Diabetes: a personalized, feature-rich, free content area consisting of all Prevention's superior diabetes coverage at http://www.diabetes.prevention.com. Outsmart Diabetes joins Prevention's overall diabetes platform, which includes books, DVD's, special interest publications and bookazines.

20 Jan 2011

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

Health care systems around the world are failing to use evidence obtained through research when making decisions, causing inefficiencies and reduced quantity and quality of life, according to a leading expert in the field of "knowledge translation."

20 Jan 2011

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Apricus Biosciences, Inc. today announced that an additional analysis conducted on behalf of the Company has shown that MycoVa™ has successfully demonstrated 'non-inferiority' for the treatment of onychomycosis (commonly referred to as nail fungus), compared to the current standard of care in Europe for topical therapy, Loceryl®.

20 Jan 2011

Legionnaires’ disease scare in Bali: Australian tourists warned

Commonwealth chief medical officer Jim Bishop has warned Australians who have returned from Bali on an outbreak of Legionnaires’ disease on the popular Indonesian resort island. The Australian health authorities knew of 11 cases of Legionnaires’ disease detected in Victorians and Western Australians after holidays in the Kuta area of Bali between August 2010 and January 2011.

19 Jan 2011

Salk Institute uncovers presenilin's productive side

Mutant presenilin is infamous for its role in the most aggressive form of Alzheimer's disease-early-onset familial Alzheimer's-which can strike people as early as their 30s. In their latest study, researchers at the Salk Institute uncovered presenilin's productive side: It helps embryonic motor neurons navigate the maze of chemical cues that pull, push and hem them in on their way to their proper targets.

19 Jan 2011

Novo Nordisk's new insulin pen for children receives 2010 GOOD DESIGN Award

A 2010 GOOD DESIGN Award has been awarded to Novo Nordisk for NovoPen Echo, the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives.

From Novo Nordisk 19 Jan 2011

CJPS Medical Systems to launch VitalPoint Remote Patient Monitor in the U.K.

CJPS Medical Systems are launching into the U.K. market this week their VitalPoint® Remote Patient Monitor, a medical device capable of measuring patients' vital signs from home, allowing secure and direct communication with their caregiver, creating electronic medical records, and transmitting vital signs data.

19 Jan 2011

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Geron Corporation today announced enrollment of the first patient in a Phase 2 clinical trial to evaluate the activity of the company's telomerase inhibitor drug, imetelstat (GRN163L), in patients with essential thrombocythemia (ET).

19 Jan 2011

Health care reform should mend disconnect between USPSTF recommendations and Medicare coverage

Health care reform should be able to mend a disconnect that has existed between the recommendations of the U.S. Preventive Services Task Force (USPSTF), a task force charged by the government to review clinical preventive health services for older adults, and Medicare coverage for those services, a new UCLA-led study finds.

19 Jan 2011

BHI, NHLBI and AHA join to promote American Heart Month and National Wear Red Day

The Better Hearing Institute (BHI) announced today that it is joining with the National Heart, Lung, and Blood Institute (NHLBI) and the American Heart Association (AHA) to promote American Heart Month in February and to celebrate National Wear Red Day® on February 4, 2011.

19 Jan 2011

Loyola offers new, nonsurgical treatment for Dupuytren's contracture

Loyola University Health System is among the first centers to offer a new, nonsurgical treatment for Dupuytren's contracture, a debilitating condition that curls fingers toward the palm.

19 Jan 2011

Diabetes News and Research

Latest Diabetes News and Research

VIVUS holds End-of-Review meeting with FDA for QNEXA NDA

What protects certain diabetics from complications?

Fat linked with DNA chemical changes may help identify risk of cardiovascular disease, diabetes

Employees with heart attack, ACS are major source of health costs

Successful larynx transplant for Californian woman

Genetic expression can be modified with natural substances to prevent chronic illness

Novo Nordisk to appeal against ruling in repaglinide combination patent case

Takeda Cambridge, Evotec enter collaboration to identify novel modulators against GPCR

Endothelial cells may play a role in controlling cancer behavior: New study

Prevention launches free content area on diabetes

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Legionnaires’ disease scare in Bali: Australian tourists warned

Salk Institute uncovers presenilin's productive side

Novo Nordisk's new insulin pen for children receives 2010 GOOD DESIGN Award

CJPS Medical Systems to launch VitalPoint Remote Patient Monitor in the U.K.

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Health care reform should mend disconnect between USPSTF recommendations and Medicare coverage

BHI, NHLBI and AHA join to promote American Heart Month and National Wear Red Day

Loyola offers new, nonsurgical treatment for Dupuytren's contracture

Mastering RNA extraction for plant and fungal research – eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Diabetes News and Research

Latest Diabetes News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in